What is HC Wainwright’s Estimate for ALLO Q1 Earnings?
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) – Equities research analysts at HC Wainwright issued their Q1 2026 earnings per share estimates for Allogene Therapeutics in a report released on Monday, June 2nd. HC Wainwright analyst R. Burns anticipates that the company will post earnings per share of ($0.27) for the quarter. HC Wainwright currently […]
